Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elevance Health Inc ELV

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.


NYSE:ELV - Post by User

Bullboard Posts
Next >>
Post by whytestockson Jul 17, 2024 10:47pm
58 Views
Post# 36137735

Elevance Health Reports Second Quarter 2024 Results

Elevance Health Reports Second Quarter 2024 Results
Breaking News: $ELV Elevance Health Reports Second Quarter 2024 Results2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...ELV - Elevance Health Reports Second Quarter 2024 Results

Bullboard Posts
Next >>